These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 694908)

  • 61. Kidney transplant recipients with long incubation-positive antiglobulin-negative T cell crossmatches.
    Pettaway CA; Freeman C; Helderman JH; Stastny P
    Transplantation; 1987 Oct; 44(4):529-33. PubMed ID: 3313840
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Attempt at blocking HLA-A, B, C antigens on lymphocytes with anti-beta 2-microglobulin SwAHu/B2m USOL. Negative result].
    Májský A
    Cas Lek Cesk; 1983 Jan; 122(2):40-3. PubMed ID: 6186376
    [No Abstract]   [Full Text] [Related]  

  • 63. HLA antibody formation within the HLA-A1 crossreactive group in multitransfused platelet recipients.
    MacPherson BR
    Am J Hematol; 1989 Apr; 30(4):228-32. PubMed ID: 2784623
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunogenicity of HLA antigens purified from serum.
    Ferrone S; Mittal KK; Pellegrino MA; Allison JP; Reisfeld RA
    Transplantation; 1977 Jan; 23(1):7-15. PubMed ID: 65035
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation.
    Mulder A; Kardol MJ; Arn JS; Eijsink C; Franke ME; Schreuder GM; Haasnoot GW; Doxiadis II; Sachs DH; Smith DM; Claas FH
    Mol Immunol; 2010 Jan; 47(4):809-15. PubMed ID: 19931911
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Study of a complex supertypic serum.
    Tongio MM; Mayer S
    Transplantation; 1974 Aug; 18(2):163-71. PubMed ID: 4858500
    [No Abstract]   [Full Text] [Related]  

  • 67. Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.
    Trinchieri G; Bauman P; De Marchi M; Tökés Z
    J Immunol; 1975 Jul; 115(1):249-55. PubMed ID: 125298
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Constancy of cross reactivity patterns during the anti-HL-A response.
    Longo A; Tosi RM; Ferrara G; Azzolina G; Carminati G
    Transplantation; 1975 Dec; 20(6):503-11. PubMed ID: 1209727
    [TBL] [Abstract][Full Text] [Related]  

  • 69. I region-associated antigen system (Ia) of the mouse H-2 gene complex. Further definition of Ia secificities with restricted anti-Ia antisera.
    David CS; Shreffler DC
    Transplantation; 1974 Oct; 18(4):313-21. PubMed ID: 4138471
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical relevance of anti-HLA antibodies pre and post transplant.
    Kerman RH; Orosz CG; Lorber MI
    Am J Med Sci; 1997 May; 313(5):275-8. PubMed ID: 9145036
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Search for cross-reactivity between HLA B27 and Klebsiella pneumoniae.
    Archer JR
    Ann Rheum Dis; 1981 Aug; 40(4):400-3. PubMed ID: 7020615
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relatively high levels of anti-HLA antibodies (measured by Luminex Single-Antigen bead assay) are required to mediate inhibition of lymphocyte proliferation induced by sera from alloimmunized renal patients.
    Mata Molanes JJ; Burgos Rodríguez L; Delgado García JA; Pérez-Robles C; Moreno Narro L; Arana Berganza P; Chocarro de Miguel S; Merino Roncal J; Moreno Parado C; Sánchez-Ibarrola A
    Ann Transplant; 2014 Dec; 19():652-9. PubMed ID: 25512058
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bw21 partition and crossreactivity of the components.
    Grumet FC; Colombe BW; Goodfellow P
    Tissue Antigens; 1978 Jan; 11(1):39-44. PubMed ID: 75587
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reduction of error rates in the microlymphocytotoxicity test.
    Perdue S; Terasaki PI; Hong J; Estrin M
    Tissue Antigens; 1977 May; 9(5):259-66. PubMed ID: 70083
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cross-reactivity between human and murine lymphocyte antigens. IV. Reactivity of H-2 alloantisera with HLA-A, B antigens.
    Quaranta V; Pellegrino MA; Callahan GN; Ferrone S
    Immunogenetics; 1981; 13(4):311-7. PubMed ID: 6168581
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anti-H-2Dd antibodies cross-react with HLA--A11 and Aw31.
    Iványi P; van den Berg-Loonen E; de Greeve P
    Tissue Antigens; 1978 May; 11(5):439-42. PubMed ID: 694908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cross-reactions of mouse anti-H-2 sera with human HL-A antigens.
    Ivasková E; Macurová H; Bavorová H; Micková M; Iványi P
    Haematologia (Budap); 1974; 8(1-4):273-9. PubMed ID: 4461424
    [No Abstract]   [Full Text] [Related]  

  • 78. Reactivity of anti-HLA sera against mouse lymphocytes.
    Colombani J; Colombani M; Degos L; David CS; Shreffler DC
    Tissue Antigens; 1977 Feb; 9(2):111-20. PubMed ID: 65803
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cross-reactions of HLA antibodies: VII. Rate of sensitization and serological specificity.
    Kostyu DD; Bernard NF; Amos DB
    Tissue Antigens; 1979 Apr; 13(4):298-306. PubMed ID: 88777
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alloimmune anti-H-2 mouse sera inhibit human mixed lymphocyte reactions.
    Sůla K; Rychlíková M; Iványi P
    Folia Biol (Praha); 1977; 23(4):263-72. PubMed ID: 143377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.